EndoTech is officially launching its Copy Trading technology on a Tier 1 Exchange
EndoTech is officially launching its Copy Trading technology on a Tier 1 Exchange 🔥
This is completely separate from Daisy — this is pure EndoTech expansion 🌍
As the Daisy community, we are shareholders of EndoTech and collectively own 20% of the company 💎 That means we are not just participants… we are owners.
And yes — shareholders receive dividends every month 💰📈
Major growth. Major exposure. Major opportunity.
The next chapter is loading ⚡
